Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-77P is a **pseudogene** member of the U6 small nuclear RNA-encoding gene family. U6 snRNA itself is a critical noncoding RNA component of the spliceosome, essential for pre-mRNA splicing in eukaryotes[2][3], but pseudogenes like RNU6-77P do not generate a functional snRNA product and are generally considered non-functional remnants in the genome[1][4]. Pseudogenes arise from duplication or retrotransposition events and typically lack regulatory sequences or contain disabling mutations. The presence of many U6 pseudogenes in the genome underscores the evolutionary importance of this RNA family but does not confer any direct biological or therapeutic role to RNU6-77P itself[3][4]. If you are seeking information about functional U6 snRNA, it is a small nuclear RNA critical for catalyzing pre-mRNA splicing within the spliceosome, highly conserved and essential for eukaryotic cell survival[2][3]. However, RNU6-77P specifically is not this functional molecule, and therefore should not be included in repositories of therapeutic drug targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 77, pseudogene (RNU6-77P).